Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery disease
- 1 October 1990
- journal article
- medical science
- Published by Elsevier in The Lancet
- Vol. 336 (8719) , 827-830
- https://doi.org/10.1016/0140-6736(90)92336-g
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Superior antiplatelet action of alternate day pulsed dosing versus split dose administration of aspirinThe American Journal of Cardiology, 1989
- Final Report on the Aspirin Component of the Ongoing Physicians' Health StudyNew England Journal of Medicine, 1989
- Aspirin, Heparin, or Both to Treat Acute Unstable AnginaNew England Journal of Medicine, 1988
- Current concepts in unstable myocardial ischemiaAmerican Heart Journal, 1988
- Secondary prevention of vascular disease by prolonged antiplatelet treatmentBMJ, 1988
- Predictive importance of clinical findings and a predischarge exercise test in patients with suspected unstable coronary artery diseaseThe American Journal of Cardiology, 1987
- Aspirin, Sulfinpyrazone, or Both in Unstable AnginaNew England Journal of Medicine, 1985
- Mechanisms contributing to precipitation of unstable angina and acute myocardial infarction: Implications regarding therapyThe American Journal of Cardiology, 1984
- Protective Effects of Aspirin against Acute Myocardial Infarction and Death in Men with Unstable AnginaNew England Journal of Medicine, 1983
- TRIAL OF HEPARIN VERSUS ATENOLOL IN PREVENTION OF MYOCARDIAL INFARCTION IN INTERMEDIATE CORONARY SYNDROMEThe Lancet, 1981